Assessment of Coronary Plaque Composition

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Coronary AtherosclerosisEndothelial DysfunctionCoronary Small Vessel Disease
Interventions
DEVICE

LipiScan/LipiScan IVUS

Evaluation of the coronary artery using near infrared spectroscopy using either a LipiScan catheter or a LipiScan/IVUS catheter following a clinically indicated coronary angiogram and endothelial function testing with a positive diagnosis of endothelial dysfunction. The procedure is repeated following 6 months of Lp-PLA2 inhibition.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER